AOD-9604
Targeted fat burning / lipolysis. Researched under SubQ administration, reported half-life ~30 min.
Research use only. Not for human consumption. Not medical advice. 18+.
Researched areas of interest
- Targeted fat burning / lipolysis
- GH fragment with no IGF-1 or anabolic effect
- Cartilage & joint repair potential
- Safer fat-loss profile than full GH
Evidence status
Human trial data
Best-evidenced fat-loss peptide, Phase 2/3 human trial data.
Grades are assigned from the published evidence position, not from how widely a compound is discussed. How grading works.
Handling notes
Research-use. No blood glucose impact. Phase 2/3 obesity trials completed but not approved.
Reconstitution reference
At the common presentation of 5 mg reconstituted with 2 ml of bacteriostatic water, the concentration is 2.5 mg/ml. Draw volumes on a U-100 syringe:
| Reference point | Volume | U-100 units |
|---|---|---|
| 0.5 mg | 0.2 ml | 20.0 IU |
| 1 mg | 0.4 ml | 40.0 IU |
| 1.5 mg | 0.6 ml | 60.0 IU |
Arithmetic reference only. These are literature reference points, not a dosing recommendation. Open the full calculator.
Available as research material
| Product | Specification | Per box |
|---|---|---|
| AOD-9604 | 5mg × 10 | $199.5 |
| AOD-9604 | 10mg × 10 | $361.5 |
From $199.5 per box. One price is one box, not one vial. Supplied by an independent laboratory supplier, not by TRAINNORTH:LABS.
Research enquiry via WhatsAppDisclaimer — Research Use Only. Materials referenced on this page are for laboratory research only. They are not intended for human consumption, are not approved as medicines in the United Kingdom unless explicitly stated, and nothing here is medical advice or a dosing protocol. Consult a qualified physician before making any health decision.
← Back to the library